Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Scilex Holding Company ( (SCLX) ) has provided an announcement.
On January 29, 2026, Scilex Holding Company entered into a $20 million convertible promissory note with Quantum Scan Holdings, Inc. (Q Scan), which fully converted the same day into 140,379,226 shares of Q Scan common stock instead of remaining as interest-bearing debt. Also on January 29, 2026, Scilex signed a common stock purchase agreement to acquire an additional 193,021,436 Q Scan shares for approximately $27.5 million, with closing to occur within five business days after Q Scan’s written notice, significantly increasing Scilex’s equity stake and strategic influence in Q Scan; meanwhile, Scilex CFO and director Stephen Ma has been serving, without compensation to date, as Q Scan’s interim CFO since January 16, 2026, underscoring the deepening operational ties between the two companies.
More about Scilex Holding Company
Scilex Holding Company operates in the healthcare sector, with a focus on developing and commercializing pharmaceutical and medical products, and is actively engaged in strategic financial transactions to expand its holdings and influence within related healthcare and technology ventures.
Average Trading Volume: 99,938
Technical Sentiment Signal: Sell
Current Market Cap: $72.35M
Find detailed analytics on SCLX stock on TipRanks’ Stock Analysis page.